NDC 55298-038 Titralac

View Dosage, Usage, Ingredients, Routes, UNII

Product Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.
NDC Product Code:
55298-038
Proprietary Name:
Titralac
Product Type: [3]
INACTIVATED PRODUCT and EXCLUDED the from NDC Directory
Labeler Name: [5]
Inova Pharmaceuticals Pty, Ltd
Labeler Code:
55298
Start Marketing Date: [9]
01-01-2004
Listing Expiration Date: [11]
12-31-2017
Exclude Flag: [12]
I
Code Structure:
Code Navigator:

Product Characteristics

Color(s):
WHITE (C48325 - WHITE)
Shape:
ROUND (C48348)
Size(s):
12 MM
Imprint(s):
3M;TITRALAC
Score:
1
Flavor(s):
SPEARMINT (C73416 - SPEARMINT)

Product Packages

NDC Code 55298-038-10

Package Description: 100 TABLET in 1 BOTTLE, PLASTIC

Product Details

What is NDC 55298-038?

The NDC code 55298-038 is assigned by the FDA to the product Titralac which is product labeled by Inova Pharmaceuticals Pty, Ltd. The product's dosage form is . The product is distributed in a single package with assigned NDC code 55298-038-10 100 tablet in 1 bottle, plastic . This page includes all the important details about this product, including active and inactive ingredients, pharmagologic classes, product uses and characteristics, UNII information and RxNorm crosswalk.

What are the uses for Titralac?

Chew, swallow or let melt in mouth two tablets every two or three hours as symptoms occur or as directed by a physician do not take more than 19 tablets in a 24 hour period or use maximum dosage for more than two weeks

Which are Titralac UNII Codes?

The UNII codes for the active ingredients in this product are:

Which are Titralac Inactive Ingredients UNII Codes?

The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:

What is the NDC to RxNorm Crosswalk for Titralac?

RxNorm is a normalized naming system for generic and branded drugs that assigns unique concept identifier(s) known as RxCUIs to NDC products.The NDC to RxNorm Crosswalk for this produdct indicates multiple concept unique identifiers (RXCUIs) are associated with this product:
  • RxCUI: 313884 - calcium carbonate 420 MG (Ca 168 MG) Chewable Tablet
  • RxCUI: 313884 - calcium carbonate 420 MG Chewable Tablet
  • RxCUI: 313884 - calcium carbonate 420 MG (calcium 168 MG) Chewable Tablet
  • RxCUI: 404179 - Titralac 420 MG (Ca 168 MG) Chewable Tablet
  • RxCUI: 404179 - calcium carbonate 420 MG Chewable Tablet [Titralac]

* Please review the disclaimer below.

Product Footnotes

[5] What is the Labeler Name? - Name of Company corresponding to the labeler code segment of the Product NDC.

[9] What is the Start Marketing Date? - This is the date that the labeler indicates was the start of its marketing of the drug product.

[11] What is the Listing Expiration Date? - This is the date when the listing record will expire if not updated or certified by the product labeler.

[12] What is the NDC Exclude Flag? - This field indicates whether the product has been removed/excluded from the NDC Directory for failure to respond to FDA"s requests for correction to deficient or non-compliant submissions ("Y"), or because the listing certification is expired ("E"), or because the listing data was inactivated by FDA ("I"). Values = "Y", "N", "E", or "I".